Claim · claimSorter/cs-013

Cannabis's Schedule I status has no accepted medical use, the scheduling criterion is met

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

Cannabis's Schedule I status has no accepted medical use, the scheduling criterion is met

Refuted recorded as “Falsified” The Emperor Wears No Clothes

WHO ECDD (2019) recommended cannabis reclassification, finding no scientific justification for Schedule I. FDA has approved prescription cannabidiol (CBD), dronabinol, nabilone (cannabinoid pharmaceuticals). DOJ proposed rescheduling to Schedule III (May 2024). 38 states have medical cannabis programs. The 'no accepted medical use' criterion is contradicted by FDA's own approval record.

Herer (1985); WHO ECDD (2019); FDA approvals